CancerX Moonshot
Ann Stadjuhar currently serves as the Head of Growth and Product at CancerX since October 2024. As the Chief Growth Officer and Partner at Decimal.health since March 2021, Ann focuses on strategic growth, go-to-market sales for digital health, encompassing enterprise software solutions, digital therapeutics, AI, patient engagement, and provider transformation. Prior experience includes founding PIpeline Genius Healthcare Consulting, where Ann provided fractional C-suite leadership and go-to-market development for healthcare startups from January 2020 to April 2022. Ann held the role of VP of Partner Digital Consumer Strategy at UnitedHealth Group from October 2016 to January 2020, emphasizing digital consumerism and organizational transformation for better healthcare outcomes. Earlier, Ann worked as a National Partner in Consumer Technology at the Advisory Board from October 2015 to April 2018, advising on market approaches within healthcare. Ann obtained a Bachelor of Arts in History from the University of Colorado Boulder.
This person is not in any teams
This person is not in any offices
CancerX Moonshot
1 followers
CancerX is a public-private partnership announced by The White House as a national accelerator to boost innovation in the fight against cancer as part of the reignited Cancer Moonshot. Co-hosted by Moffitt Cancer Center and Digital Medicine Society (DiMe), we convene the many diverse stakeholders needed to unleash the power of innovation to fight cancer. Mission: To unite a diverse and inclusive community of stakeholders and harness our collective superpowers to rapidly pioneer and equitably deploy innovative solutions that can prevent and cure cancer. Goal: To convene the many stakeholders necessary to create, foster, accelerate, and scale the impact of a community of innovators dedicated to reducing the burden of cancer for all people.